Robert Rifkin, MD, FACP, and Tommy Pourmahram

Robert Rifkin, MD, FACP, is medical director of Biosimilars for McKesson, associate chair of Hematology Research for The US Oncology Network, and an oncologist/hematologist with Rocky Mountain Cancer Centers in Denver, Colorado. Tommy Pourmahram is vice president of Multi-Source Products & Analytics for McKesson in Houston, Texas.




 
Aug 1, 2020 @11:00 AM

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars® is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2020 Intellisphere, LLC. All Rights Reserved.